The transcription factors Foxo1, Foxo3 and Foxo4 modulate cell fate 'decisions' in diverse systems. Here we show that Foxo1-dependent gene expression was critical at many stages of B cell differentiation. Early deletion of Foxo1 caused a substantial block at the pro-B cell stage due to a failure to express interleukin 7 receptor-a. Foxo1 inactivation in late pro-B cells resulted in an arrest at the pre-B cell stage due to lower expression of the recombination-activating genes Rag1 and Rag2. Deletion of Foxo1 in peripheral B cells led to fewer lymph node B cells due to lower expression of L-selectin and failed class-switch recombination due to impaired upregulation of the gene encoding activation-induced cytidine deaminase. Thus, Foxo1 regulates a transcriptional program that is essential for early B cell development and peripheral B cell function.
B cell commitment, survival and immunoglobulin assembly are all products of a carefully orchestrated network of transcription factors that guide gene expression 1 . In hematopoietic stem cells, 'graded' expression of the transcription factors PU.1 and Ikaros direct development away from the myeloid lineage and toward common lymphoid progenitors 2, 3 . Deletion of either PU.1 or Ikaros in mice leads to a block in the differentiation of hematopoietic stem cells into common lymphoid progenitors and lack of expression of 'downstream' B cellspecific transcription factors. Although the microenvironmental cues that direct early B cell commitment and differentiation are not entirely understood, expression of interleukin 7 receptor (IL-7R; A001267) and the receptor tyrosine kinase Flt3 is critical 1 . The transcription factors E2A, EBF and Pax5 are each required for the transition from common lymphoid progenitor to the pro-B cell stage [4] [5] [6] . As for transcriptional hierarchy, E2A regulates expression of the genes encoding EBF and Pax5, as ectopic expression of the gene encoding EBF can restore B cell-specific gene expression in E2A-deficient cells 7 . B cells that reach the pre-B cell stage require the functions of the transcription factors IRF4 and IRF8 to cease expression of components of the pre-B cell antigen receptor (pre-BCR) and to promote expression of the recombination-activating genes Rag1 and Rag2 (collectively called 'Rag' here; refs. 8, 9) . Better understanding of the early B cell transcriptional network has evolved, but the inability of known transcription factors to completely 'rescue' the developmental block(s) in gene-ablation models suggests that additional factors and feedback mechanisms exist.
In addition to their functions in early B cell development, many of these same regulatory factors seem to act in the differentiation and activation of peripheral B cells. Forced expression of PU.1, which has low expression in mature B cells, diminishes the ability of peripheral B cells to switch to immunoglobulin G1 (IgG1) after in vitro stimulation 10 . Similarly, activated B cells overexpressing a chief E2A antagonist, Id3, fail to induce expression of activation-induced cytidine deaminase (AID), which suggests that E2A regulates the gene encoding AID (Aicda) 11 . Finally, it has also been shown that IRF4 has a dual function in the differentiation of peripheral B cells by promoting Aicda expression and regulating the generation of plasma cells 12, 13 .
The phosphatidylinositol-3-OH kinase (PI(3)K) pathway is important in both B cell development and the maturation and function of peripheral B cells. Deletion of the catalytic or regulatory subunits of PI(3)K in B cells leads to impairments in B cell development and decreases in peripheral B cell subsets (follicular, marginal zone and B-1) 14 . Conversely, inactivation of the inositol phosphatase PTEN, which is the enzymatic antagonist of PI(3)K, results in the population expansion of B-1 and marginal zone B cells 15, 16 . PI(3)K is activated by the BCR and other receptors on B cells, which results in the transient production of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ). PtdIns(3,4,5)P 3 binds to the pleckstrin homology domain of various effector proteins (such as the kinase Akt), which results in recruitment to the plasma membrane and activation. Transcriptional regulation 'downstream' of PI(3)K is accomplished in part by members of the evolutionarily conserved decay-accelerating factor 16-related forkhead O (Foxo) family, which consists of Foxo1 (A000944), Foxo3 (A000945) and Foxo4 (A002832). Phosphorylation of the Foxo proteins by Akt at three conserved sites induces their nuclear export and consequent inactivation of transcriptional activity 17 . Known targets of Foxo factors include genes encoding the cell cycle regulators p27 and cyclin D2, the proapoptotic factors Bim and Fas ligand, and the regulators of reactive oxygen species MnSOD and GADD45 (ref. 17) . Deletion of all Foxo factors in hematopoietic stem cells leads to a considerable block in the generation of common lymphoid progenitors due to impaired protection from reactive oxygen species 18 . From the analysis of the Foxo transcriptome in various lineages, it is apparent that the Foxo factors regulate their many targets in a highly context-specific way with almost no overlap from one cell type to the next 18, 19 , which emphasizes the need for direct analysis of Foxo actions in specific physiological settings. Of relevance to our study here, it is notable that although all three Foxo factors are expressed in B cells, their unique and redundant functions in the development and activation of B cells have not been elucidated.
Here we used many gene-targeting approaches to determine the unique and redundant functions of Foxo1 and Foxo3 in B cell development and activation. Germline inactivation of Foxo3 did not impair early B cell generation, the formation of immunoglobulinpositive B cells or peripheral B cell differentiation or antibody responses. Conversely, selective deletion of Foxo1 at discrete stages of B cell development identified specific functions for Foxo1 at many B cell checkpoints. Inactivation of Foxo1 in the early pro-B cell, pre-B cell or transitional B cell compartments resulted in impaired B cell differentiation associated with lower expression of the Il7ra, Rag1, Rag2, Sell (which encodes L-selectin (CD62L)) and Aicda. Our findings establish Foxo1 as a critical member of the transcription factor network that directs early B cell development and peripheral immune function. 
RESULTS

Foxo1 is required for expression of IL-7Ra and RAG
IL-7Rα
Foxo3 β-actin 0.6 11.1 20 . The mb1 Cre mice express Cre at an early B lymphoid progenitor stage, which mediates deletion of loxPflanked genes at the earliest pro-B cell stage of development. We compared the resultant Foxo1 L/L mb1 Cre mice with wild-type (Foxo1 +/+ mb1 Cre ) littermate controls as well as with Foxo3-null (Foxo3 -/-) mice 21 .
We analyzed peripheral lymphoid organs by flow cytometry to count the cells in various B cell subsets. In the spleen, lymph nodes and peripheral blood, Foxo1 L/L mb1 Cre mice had 10% of the B cells that wild-type or Foxo3 -/mice had (Fig. 1a ). In addition, Foxo1-deficient B cells present in the periphery did not have surface expression of IgM or IgD (Fig. 1a ). As reported before 22 , Foxo3 -/mice had more total cells; however, their B cell numbers were not significantly higher than those of wild-type littermate controls ( Fig. 1b) . Because Foxo1 L/L mb1 Cre mice had many fewer peripheral B cells, we examined the B cell compartment of the bone marrow from Foxo1 L/L mb1 Cre mice to determine if B cell development was blocked at an early stage. Indeed, Foxo1 L/L mb1 Cre mice had a lower percentage of total B cells in the bone marrow than did wild-type mice ( Fig. 1c) , consistent with efficient deletion of Foxo1 in early B cells ( Supplementary Fig. 1a online). Close analysis of the bone marrow also showed much lower percentages of B220 + IgM + immature and mature B cells and of B220 + CD43 -IgMpre-B cells relative to those of wild-type and Foxo3 -/mice ( Fig. 1c ). In addition, the Foxo1 L/L mb1 Cre mice had a twofold higher percentage of B220 + CD43 + pro-B cells (Fig. 1c) . On the basis of differential display of cell surface markers, pro-B cells can be further subcategorized into three stages of development: pre-pro-B, early pro-B and late pro-B. Foxo1 L/L mb1 Cre mice had significantly lower percentages of pro-B cells that were CD19 + BP1 -(early pro-B) and CD19 + BP1 + (late pro-B) but a higher percentage of CD19 -BP1 -(prepro-B) cells ( Fig. 1c,d ). Semiquantitative RT-PCR analysis of cDNA showed generally lower expression of genes known to be critical for early B cell differentiation in pro-B cells from Foxo1 L/L mb1 Cre mice ( Fig. 1e and Supplementary Fig. 2 online) . Whether these genes are direct or indirect targets of Foxo1 will require further investigation. These results collectively suggest that B cell development in Foxo1 L/L mb1 Cre mice is partially blocked at the transition from prepro-B to early pro-B and that very few B cells progress beyond the cycling pre-B stage.
A pro-B cell block in development can occur because of two main types of defects. One defect is marked by failed IL-7R signaling, which results in more cell death and less proliferation 23, 24 . The second defect, such as that in Rag2 -/mice, is attributed to failed pre-BCR assembly and signaling. The earliest stages of B cell development are dependent on IL-7 signaling, with a gradual transition to pre-BCR-dependent proliferation and differentiation. In Foxo1 L/L mb1 Cre mice, pro-B cell populations failed to expand in IL-7-conditioned cultures (data not shown), which indicated that these cells could have defects in cell proliferation and or survival. Because IL-7Ra is necessary for IL-7 signaling at the pro-B cell stage, we analyzed IL-7Ra expression by flow cytometry. Although wild-type pro-B cells had high expression of IL-7Ra, Foxo1 L/L mb1 Cre mice did not upregulate IL-7Ra at the pro-B cell stage ( Fig. 2a ). To assess whether the lack of IL-7R in Foxo1deficient pro-B cells had an effect on the survival of pro-B cells, we analyzed annexin V expression on pro-B cells from Foxo1 L/L mb1 Cre and wild-type mice. Although wild-type pro-B cells included relatively few (15%) annexin V-positive apoptotic cells, such cells represented the majority (55%) of the pro-B cells in Foxo1 L/L mb1 Cre mice Foxo1 +/+ mb1 Cre = 15% ( Fig. 2b) , which indicated that Foxo1-deficient B cells are prone to apoptosis at this stage of development.
To gain insight into the mechanisms of Foxo1 L/L mb1 Cre pro-B cell death, we analyzed the expression of Bim and Bcl-x L , pro-and antiapoptotic members, respectively, of the family of the antiapoptosis protein Bcl-2. Flow cytometry showed that freshly isolated pro-B cells from Foxo1 L/L mb1 Cre mice had higher expression of Bim and lower expression of Bcl-x L (Fig. 2c,d ). Overexpression of either Bcl-2 or Bcl-x L has been shown to attenuate apoptosis, and a transgene encoding Bcl-x L allows the population expansion and survival of pro-B cells 25 . To determine if early B cell development could be restored by protection of Foxo1-deficient B cells from apoptosis, we expanded populations of Foxo1 L/L pro-B cells that did not express Cre in medium containing IL-7, then transduced the cells with a mouse stem cell-based retrovirus encoding Bcl-x L . Then, 2 d later, we did secondary infection with empty virus (MIT) or Cre-expressing virus (MIT-Cre) to eliminate Foxo1. Although induced deletion of Foxo1 in the absence of exogenous Bcl-x L resulted in rapid cell death, Foxo1 L/L cells expressing both Bcl-x L and Cre survived in culture but did not proliferate ( Fig. 2e,f) . Thus, promotion of the survival of Foxo1deficient pro-B cells is necessary but not sufficient to 'rescue' the developmental block in Foxo1 L/L mb1 Cre mice.
In addition to having a defect in survival, Foxo1 L/L mb1 Cre pro-B cells failed to express normal amounts of intracellular m-heavy chain ( Fig. 3a) . Foxo1 L/L mb1 Cre and Rag2 -/mice had similar staining patterns for m-heavy chain at the pro-B cell stage ( Fig. 3a) . To determine if Foxo1 L/L mb1 Cre cells can undergo heavy-chain immunoglobulin rearrangements, we analyzed genomic DNA from purified pro-B cells by PCR followed by Southern blot. Although diversity heavy-chain-to-joining heavy-chain (D H -to-J H ) rearrangement was normal, Foxo1 L/L mb1 Cre pro-B cells showed impaired variable heavychain (V H )-to-(D)J H rearrangement (Fig. 3b ). This result is consistent with a defect in IL-7R signaling, as IL-7 has been linked to promotion of the accessibility of the V H locus 26, 27 . It has also been shown that Rag enhancer (Erag) regions bear conserved forkheadbinding sites 28 and hence Foxo1 could directly regulate Rag expression. Indeed, we found that Foxo1 L/L mb1 Cre pro-B cells had lower transcription of Rag1 and Rag2 (Fig. 3c ). We noted similarly lower expression of Rag1 and Rag2 in cultured pre-B cells after 'acute' deletion of Foxo1 with Cre-expressing virus ( Supplementary Fig. 3 online). To determine if Foxo1 could also bind to the Erag region, we isolated chromatin from primary pre-B cells propagated in IL-7 and analyzed it by chromatin-immunoprecipitation (ChIP) analysis. Notably, Foxo1 bound to the same conserved forkhead-binding sites as the transcription factor Foxp1 did 29 (Fig. 3d ), which suggested that they regulate Rag expression together in part by binding to Erag. Additionally, ChIP data obtained with peripheral T cells suggested that Foxo1 did not bind to the Erag region when Rag was not expressed ( Supplementary Fig. 4 online) .
Foxo1 regulates j-region rearrangement in pre-B cells
To determine if Foxo1 is required beyond the pro-B cell stage, we crossed Foxo1 L/L mice with mice expressing Cre under control of the Cd19 promoter (Cd19 Cre ) 30 . Cd19 expression is induced by Pax5 and EBF at the pro-B cell stage, which conferred substantial yet partial Cd19 Cre -mediated deletion of Foxo1 in pre-B cells and immature B cells and nearly complete deletion by the mature B cell stage 29 ( Supplementary Fig. 1a,b ). The Foxo1 L/L mb1 Cre mice had normal pro-B cell and pre-B cell compartments with a smaller percentage of immature and mature B cells relative to those of wild-type (Foxo1 +/+ Cd19 Cre ) mice ( Fig. 4a,b ). In the periphery, Foxo1 L/L Cd19 Cre mice had a higher percentage of B cells in the spleen and peripheral blood and much lower percentage of B cells in lymph nodes relative to those of wild-type mice (Fig. 4c) . Notably, a prominent IgM -IgD -B cell population was present in the peripheral blood and spleens of Foxo1 L/L Cd19 Cre mice that was not present in wild-type mice ( Fig. 4c,d) . These IgM -B cells also had low expression of the B cell maturation markers CD21 and CD23 (Fig. 4e) , which suggested that they are not mature B cells. To determine if the IgM -IgD -B cells in the Foxo1 L/L Cd19 Cre mice were pre-B cells, we stained splenic B cells for surface IgM and IgD and either intracellular m-heavy chain or k-light chain. Although a high proportion of IgM -IgDwild-type B cells expressed intracellular k-light chain, which suggested that they were class-switched B cells, very few IgM -IgD -Foxo1 L/L Cd19 Cre B cells expressed intracellular kor l-light chains but had abundant expression of intracellular m-heavy chain ( Fig. 4f and Supplementary  Fig. 5 online). Consistent with those data, IgM -IgD -Foxo1 L/L Cd19 Cre B cells also had less V k -J k rearrangement as well as less excision of the V k -J k locus through downstream rearrangement with the recombination signal element (Fig. 4g) . IgM -IgD -Foxo1 L/L Cd19 Cre B cells were negative for expression of the pre-BCR components VpreB1 and l5 (data not shown), which suggested that they were small resting pre-B cells that moved to the periphery. These results are consistent with the diminished Rag expression and heavy-chain gene rearrangement found at the pro-B cell stage in Foxo1 L/L mb1 Cre mice. We also crossed Foxo1 L/L Cd19 Cre mice onto the Foxo3 -/background. The B cell compartment of these mice was indistinguishable from that of their Foxo1 L/L Cd19 Cre counterparts ( Supplementary Fig. 6 online), which indicated that the functions we have ascribed to Foxo1 were unaffected by the presence or absence of Foxo3.
Foxo1 is required for expression of AID and CD62L
The prominent defects in early B cell development in Foxo1 L/L mb1 Cre and Foxo1 L/L Cd19 Cre mice precluded analysis of the maturation and function of peripheral B cells. Therefore, we crossed Foxo1 L/L mice with mice that express Cre under control of the promoter of Cr2 (called 'Cd21' here; Cd21 Cre mice) 31 . These mice upregulate Cre during the transitional stage of B cell development, after IL-7dependent differentiation, immunoglobulin gene rearrangement and, presumably, RAG-mediated receptor editing has occurred. Flow cytometry showed that Foxo1 L/L Cd21 Cre mice had a modestly higher percentage of splenic B cells than did wild-type mice. The percentage of Foxo1 L/L Cd21 Cre B cells representing transitional B cells (IgM + IgD -CD21 -), marginal zone B cells (CD9 hi CD21 hi ) and mature B cells (IgM + IgD + ) was normal relative to that of wild-type B cells ( Fig. 5a and data not shown). Although expression of IgM and IgD was slightly lower, we did not find more IgM -IgD -B cells, consistent with their postulated pre-B origin. Notably, these mice had about 30% fewer lymph node B cells, which was consistent with lower expression of L-selectin (CD62L) and homing defects (Fig. 5a) . We also noted lower expression of CD62L on peripheral B cells in Foxo1 L/L Cd19 Cre mice (data not shown). In the peritoneal cavity, there were fewer B-1 cells; this seemed to affect mainly CD5 + B-1a cells (Fig. 5b) . These findings suggest that Foxo1 regulates the homing of peripheral B cells through upregulation of CD62L. Consistent with their lower surface immunoglobulin expression, Foxo1 L/L Cd21 Cre splenic B cells had lower survival in response to crosslinking of the BCR with antibody to IgM (anti-IgM) F(ab¢) 2 , as determined by flow cytometry to analyze cell death (Fig. 5c ). The survival defect was dose dependent and activation induced, as submitogenic amounts of anti-IgM did not demonstrate differences between Foxo1 L/L Cd21 Cre and wild-type B cells (Fig. 5c) . These defects were associated with more Bim expression, as was the case with Foxo1deficient pro-B cells (Fig. 5d) . The effects noted were BCR specific, as the survival of Foxo1-deficent B cells was similar to that of wild-type cells after stimulation with lipopolysaccharide (LPS) and IL-4 ( Fig. 5c ). Notwithstanding the effects of Foxo1 loss on surface BCR expression, Foxo1 does not seem to be required for B cell maintenance but may contribute to survival after activation. In accordance with their diminished survival, Foxo1 L/L Cd21 Cre B cells proliferated less in response to stimulation with low concentrations of anti-IgM F(ab¢) 2 and intact anti-IgM, whereas the proliferation of Foxo1-deficient B cells was similar to that of wildtype cells in response to LPS and IL-4 ( Fig. 6a ). Foxo1 L/L Cd21 Cre B cells also had less anti-IgM-dependent phosphorylation of the kinases Akt and Erk (Fig. 6b ) and had less calcium flux in response to stimulation with anti-IgM F(ab¢) 2 (Fig. 6c) . Despite the BCR signaling defects noted in vitro, immunization of Foxo1 L/L Cd21 Cre mice with the T cell-independent type 2 (TI-2) antigen trinitrophenol-Ficoll (TNP-Ficoll) elicited abundant production of TNP-specific serum IgM (Fig. 6d) . Naive Foxo1 L/L Cd21 Cre mice also had slightly more polyreactive natural antibody at day 0 ( Fig. 6d) . This observation correlated with the retained B-1b population in the peritoneal cavity, which was able to respond to TI-2 antigens. Notably, immunization of Foxo1 L/L Cd21 Cre mice with TI-2 antigen produced very low titers of IgG3 antibody relative to that of wild-type mice (Fig. 6d) . To determine if Foxo1 L/L Cd21 Cre B cells could respond normally to T cell-dependent antigens, we immunized mice with nitrophenol-keyhole limpet hemocyanin (NP-KLH) and analyzed concentrations of serum immunoglobulin 7 d and 14 d later.
Serum antibody from Foxo1 L/L Cd21 Cre mice again showed more nitrophenol-specific IgM at days 7 and 14 but an absence of detectable IgG at both time points (Fig. 7a) . To discern whether the absence of IgG was due to less germinal center formation, we assessed the presence of germinal center B cells in splenic cell suspensions and tissue sections. In both analyses, Foxo1 L/L Cd21 Cre mice showed germinal center responses to NP-KLH similar to those of wild-type mice (Fig. 7b,c) , which suggested that the lack of IgG production was due to a general defect in class-switch recombination (CSR) and was not due to impaired T cell-B cell 'collaboration' .
In the absence of PTEN, B cells do not undergo CSR in response to stimulation with antigen or with LPS and IL-4 either in vivo or in vitro, and this CSR defect can be partially 'rescued' by the expression of a constitutively active Foxo1 gene 32 . To determine if Foxo1-deficient B cells can undergo CSR, we stimulated cells for 3 d in vitro with LPS and IL-4 and analyzed their proliferation, CSR and plasma cell formation. Although wild-type B cells underwent both CSR and plasma cell formation efficiently after stimulation, there was notably less CSR and enhanced plasmablast generation in the absence of Foxo1 (Fig. 8a) . These cells also did not undergo CSR after addition of the PI(3)K-d inhibitor IC87114, which increases CSR in wild-type as well as in PTEN-deficient B cells 33 , consistent with the function of Foxo1 as the 'downstream' nuclear target of PI(3)K (Fig. 8b) . To determine if expression of AID, the 'master' regulator of both CSR and somatic hypermutation, was defective in Foxo1 L/L Cd21 Cre B cells, we analyzed Aicda expression in RNA from in vitro-stimulated cells. Foxo1-deficient B cells did not upregulate expression of Aicda or generate post-switch IgG1 transcripts in response to stimulation with LPS and IL-4, but locus accessibility leading to germline transcript expression was unaffected (Fig. 8c) . To confirm those in vitro findings with in vivo expression of Aicda, we prepared cDNA from purified 
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IgM B cells from Foxo1 L/L Cd21 Cre , Foxo3 -/and wild-type mice and analyzed it by RT-PCR. As expected, Aicda expression was lower in Foxo1 L/L Cd21 Cre B cells, whereas Foxo3 -/and wild-type B cells had similarly high expression ( Fig. 8d) . Thus, the Foxo1-associated defect in CSR is linked to Aicda transcription.
DISCUSSION
The generation and function of peripheral B cell subsets results from an elaborate series of cellular and molecular events often associated with developmental checkpoints. Transcriptional regulation of these events controls B cell commitment, survival and proliferation, as well as B cell-specific processes such as immunoglobulin gene rearrangement, CSR and terminal differentiation into plasma cells. Here we have demonstrated that Foxo1 exerts a nonredundant function in regulating many of these events. Two microarray studies have shown that whereas Foxo3 expression does not vary throughout B cell development, there is strong upregulation of Foxo1 at the early pro-B cell stage in humans and mice 34, 35 , which suggests that Foxo1 is the dominant family member expressed at this stage. We have shown that deletion of Foxo1 in nascent pro-B cells led to a block in B cell development due to impaired expression of IL-7Ra. Expression of Il7ra is regulated by PU.1 in lymphoid progenitors 36 . Moreover, EBF, a 'downstream' target of PU.1, can restore IL-7Ra expression and B cell commitment in PU.1-deficient fetal liver hematopoietic progenitor cells 37 . Because EBF controls mb1 expression and hence mb1 Cre expression, the requirement for Foxo1 in regulating sustained expression of Il7ra in early B cells occurs after the onset of EBF expression, which suggests a hierarchy of transcriptional control. Lack of IL-7Ra expression resulted in apoptosis of Foxo1-deficient pro-B cells. Notably, more apoptosis of Foxo1-deficient pro-B cells correlated with higher Bim expression, despite earlier reports that Bim is a Foxo-induced gene product in several cell types 38 . The frequency of pro-B cells expressing Bcl-x L was lower in the absence of Foxo1. This finding is consistent with lower expression of IL-7R, which induces Bcl-x L expression after activation of the STAT5 transcription factor 39 . IL-7-dependent pro-B cell survival was restored by ectopic Bcl-x L expression in vitro, but this manipulation was not sufficient to overcome IL-7R-dependent functions in early B cell proliferation and differentiation.
In addition to lacking IL-7Ra expression, Foxo1-deficient B cells had lower expression of Rag1 and Rag2, which led to impaired V(D)J rearrangement and cytoplasmic m-chain production in pro-B cells. Cd19 Cre -mediated deletion resulted in a later impairment at the pre-B cell stage and less light-chain gene rearrangement. These cells exited to the periphery and were present in the spleen but did not recirculate, perhaps because they had lower expression of L-selectin. It is also possible that Foxo1 regulates gene expression that leads to the retention of developing B cells in the bone marrow. It has been noted that the production of a functional BCR causes basal PI(3)K signaling and downregulation of RAG 40, 41 . As Foxo proteins are negatively regulated by PI(3)K, this downregulation can probably be attributed to the removal of Foxo proteins from the nucleus, equivalent to what is found in Foxo1-deficient B cells. We have shown that Foxo1 bound to the Erag region, although this may not be the only mechanism of Foxo1-dependent regulation of Rag. Notably, Foxp1, a Forkhead family member distantly related to the Foxo factors, has also been shown to regulate Rag expression in B cells through Erag binding 28 . In contrast, deletion of Foxo3 did not affect the rearrangement or assembly of immunoglobulin genes at the pro-B cell or pre-B cell stage. Thus, Foxo1 exerts a critical and nonredundant function in the rearrangement and editing of V(D)J segments.
During the preparation of this manuscript, two papers reported that Foxo factors contribute to RAG expression 29, 42 . In agreement with our findings, it has been shown that knockdown or forced expression of Foxo1 but not Foxo3 modulates Rag expression in early B cells 29 . In addition, it has been shown that overexpression of a constitutively nuclear Foxo3 molecule bearing altered Akt-phosphorylation sites is also able to upregulate Rag expression 42 . Here we have provided direct evidence that Foxo1 is required for Rag expression and that Foxo3 is dispensable for immunoglobulin gene rearrangement. In vitro studies suggest that the Foxo factors bind similar if not identical DNA targets, consistent with the high degree of sequence similarity among their DNA-binding forkhead domains 43 . Thus, post-translational regulatory mechanisms, particularly those that control protein stability, may contribute to the discrete functions of the individual Foxo factors. If this is the case, then expression of a constitutively active form of any Foxo factor may have similar effects, precluding the assignment of particular functions to individual Foxo factors.
The activation of mature B cells causes nuclear exclusion of Foxo1 and downregulation of Foxo1 transcription 32, 44, 45 . Here we have shown that Foxo1 has a distinct function in the maturation of peripheral B cells and the antibody response. Deletion of Foxo1 in transitional B cells through the use of Cd21 Cre led to fewer lymph node B cells, consistent with lower expression of L-selectin. Peritoneal B cells were also fewer in number and were considerably biased toward the CD5 -B-1b subset, whereas the marginal zone B cell compartment was intact. These findings were unexpected, as previous analyses of mice with B cell-specific PTEN deficiency showed expansion of the marginal zone and B-1a subsets in the presence of more PtdIns(3,4,5)P 3 and, presumably, inactive Foxo factors 15 . Foxo1-deficient B cells also had less BCR expression and consequent defects in BCR signaling, proliferation and survival. Similar to pro-B cells, Foxo1-deficient splenic B cells had higher expression of Bim after stimulation with high concentrations of anti-IgM F(ab¢) 2 . Despite having less BCR responsiveness and an altered B-1 cell compartment, Foxo1 L/L Cd21 Cre produced a robust T cell-independent immune response.
Foxo1 L/L Cd21 Cre mice underwent normal germinal center formation and produced abundant antigen-specific IgM after immunization with T cell-dependent antigens; however, class-switched serum antibodies were not generated. This impairment was not due to impaired T cell help, as TI-2 responses show the same defect. Moreover, in vitro differentiation assays demonstrated normal or greater plasma cell generation in the absence of accompanying CSR. Those findings are consistent with published work demonstrating a negative regulatory function for PI(3)K in CSR 33 . In addition, we also found that forced expression of nuclear Foxo1 resulted in a higher percentage of classswitched B cells and expression of Aicda in the presence or absence of a PI(3)K inhibitor 33 . We have provided genetic evidence that Foxo1 exerts an essential and nonredundant function in CSR by upregulating Aicda expression. Hence, PtdIns(3,4,5)P 3 seems to be necessary for the activation and cell cycle entry of resting B cells but must be attenuated to allow proliferation-dependent CSR to proceed. That view is consistent with the finding that strong BCR agonists suppress CSR 46 . Thus, although inactivation of Foxo1 does not strongly affect late B cell maturation and antigen-driven clonal expansion, it serves an essential function in CSR.
Our findings have collectively established pivotal functions for Foxo1 in early B cell maturation and peripheral immune function. These functions can be attributed in large part to Foxo1-dependent transcription of Il7ra, Rag1, Rag2, Sell and Aicda, although other relevant targets certainly remain. Unexpectedly, we found no evidence of enhanced survival or proliferation that would support suggestions that the Foxo proteins may be important for preventing B cell transformation. That observation did not seem to be due to redundant functions with Foxo3, as mice lacking both Foxo1 and Foxo3 in the B lineage had a phenotype indistinguishable from that of mice lacking Foxo1 alone. Future studies should address the specific function of Foxo1 in the context of other transcription factors that regulate early and late B cell differentiation.
METHODS
Mice. Mice with loxP sites flanking exon 2 of Foxo1 (ref. 19 ; Foxo1 L/L ) were crossed with Cd19-Cre 30 (Cd19 Cre ), mb1-Cre 20 (mb1 Cre ) or Cd21-Cre 31 (Cd21 Cre ) mice for deletion of Foxo1 at various stages of B cell development. Mice with a gene-trap cassette inserted into the first intron of Foxo3 were used for complete deletion of Foxo3 (Foxo3 -/-) 21 . Mice were bred and housed in the animal facility of the Burnham Institute for Medical Research and all experiments received approval from the Institutional Animal Care and Use Committee. Mice of 8-10 weeks of age were used for peripheral B cell analysis and those 4-6 weeks of age were used for bone marrow cultures.
Flow cytometry. Single-cell suspensions (1 Â 10 6 ) were first stained for 20 min at 4 1C with biotinylated and/or Fc-blocking antibodies in flow cytometry buffer (1% (vol/vol) FBS, 0.1% (wt/vol) azide in PBS), followed by incubation with a 'cocktail' of antibodies conjugated to fluorescein isothiocyanate, phycoerythrin, peridinine chlorophyll protein complex-cyanine 5.5, phycoerythrin-indotricarbocyanine, allophycocyanin or allophycocyanin-indotricarbocyanine. For intracellular staining, cell surfaces were stained first, followed by buffer fixation and permeabilization (eBioscience) and intracellular staining. Antibodies used were as follows: biotinylated anti-BP1 (6C3) and anti-IgD (11-26; both from eBioscience), anti-CD9 (KM08), anti-CD23 (B3B4), anti-CD86 (GL1), anti-IgG1 (A85-1), anti-IgG2a-IgG2b (R2-40) and anti-IgG3 (R40-82; all from BD Pharmingen); fluorescein isothiocyanate-conjugated annexin V (556419), anti-CD2 (RM2-5), anti-CD69 (HI.2F3), anti-GL7 (GL7), anti-H2Db (KH95), anti-CD21 (7G6), anti-k (187.1), anti-l (R26-46) and anti-mouse IgG1 (A85-1; all from BD Pharmingen), anti-CD5 (53-7.3), anti-IgD (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) , anti-m (II/41) and anti-rabbit (11-4839-81; all from eBioscience); phycoerythrin-conjugated anti-CD138 (281-2) and anti-CD43 (S7; both from BD Pharmingen), anti-CD23 (B3B4), anti-IgD (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) , anti-CD3e (145-2C11) and anti-CD127 (A7R34; all from eBioscience); peridinine chlorophyll protein complex-cyanine 5.5-conjugated anti-B220 (RA3-6B2) and streptavidin (both from eBioscience); phycoerythrin-indotricarbocyanineconjugated anti-CD11b (M1/70; BD Pharmingen), anti-CD3 (145-2C11; eBioscience) and streptavidin (eBioscience); allophycocyanin-conjugated anti-CD19 (ID3) and anti-CD62L (MEL-14; both from BD Pharmingen), anti-CD127 (A7R34), anti-B220 (RA3-6B2), anti-IgM (II/41) and streptavidin (all from eBioscience); and allophycocyanin-indotricarbocyanine-conjugated anti-CD19 (ID3; BD Pharmingen) and anti-B220 (RA3-6B2; eBioscience). Rabbit anti-mouse Bim (2819; Cell Signaling Technology) and anti-mouse Bcl-xL (B22620; Transduction Laboratories) were used for intracellular staining. Data were collected on a FACSCanto (BD) and were analyzed with FlowJo software (TreeStar).
Semiquantitative and quantitative RT-PCR. Bone marrow pro-B cells were purified by initial depletion of CD25 + , CD2 + , IgM + and CD11b + cells with biotinylated antibodies followed by depletion with anti-biotin beads (Militenyi). B cells were further purified (85-90% pro-B) with B220 positive selection (Militenyi). RNA was purified from cells with TRIzol LS according to the manufacturer's instructions (Invitrogen). The SuperScript II first-strand synthesis kit (Invitrogen) was used for reverse transcription. Serially diluted cDNA was used for 30 cycles of PCR with published primer pairs 47 . Quantitative RT-PCR analysis of Aicda used RNA from purified B cells from immunized mice as described 33 . Aicda expression was normalized first to that of Gapdh (encoding glyceraldehyde phosphate dehydrogenase) and then to the percentage of Fas + GL7 + germinal center B cells, as determined by flow cytometry.
Immunization and enzyme-linked immunosorbent assay (ELISA). For T cell-dependent immunization, mice were immunized intraperitoneally with 100 mg NP-KLH precipitated in alum (Imject; Pierce) and serum was collected on days 0, 7 and 14. For TI-2 immunization, mice were immunized with 10 mg TNP-Ficoll and serum was collected on days 0 and 5. ELISA for antigen-specific antibody was done as described 33 . For analysis of Aicda expression, mice were immunized intraperitoneally with 200 mg NP-KLH in alum and analyzed 10 d later.
Cell culture. Red blood cells from splenic single-cell suspensions were lysed for 5 min at 4 1C with ACK buffer (150 mM NH 4 Cl, 1 mM KHCO 3 and 0.1 mM Na 2 EDTA). B cells were purified by negative selection with CD43-labeled magnetic beads (Miltenyi). For carboxyfluorescein succinimidyl ester (CFSE) cultures, B cells were labeled for 10 min at 20 1C with 2.5 mM CFSE in PBS and washed and then were cultured for 3 d at a density of 2 Â 10 6 cells per ml in a 96-well flat-bottomed plate in RPMI medium with 10% (vol/vol) FBS (Mediatech), penicillin-streptomycin (100 U/ml), L-glutamine (2 mM) and sodium pyruvate (1 mM) with goat anti-mouse IgM F(ab¢) 2 (Jackson) or rabbit antibody to mouse intact IgM (Jackson) at a concentration of 10 mg/ml, 1 mg/ml or 0.1 mg/ml, with or without IL-4 (10 ng/ml; R&D Systems) or LPS (20 mg/ml; Sigma) plus IL-4 (10 ng/ml).
Calcium flux. Purified splenic B cells were labeled for 60 min at 37 1C with the fluorescent calcium indicator Fluo-4 (Invitrogen). Cells were washed and then were resuspended at a density of 2 Â 10 6 cells per ml and were collected on the cytometer for 15 s before stimulation. Cells were stimulated with anti-IgM F(ab¢) 2 (10 mg/ml) and were collected on the cytometer for 3 min.
Bone marrow infection. Viral supernatants were generated from transfected Phoenix-eco cells as described 33 . B cells were positively selected from bone marrow with B220-labeled magnetic beads (Miltenyi). Cells were cultured for 48 h in pre-B cell culture medium consisting of opti-MEM with 15% (vol/vol) FBS (Hyclone), penicillin-streptomycin (100 U/ml), L-glutamine (2 mM) and 2-mercaptoethanol (55 mM) with the addition of IL-7 (5 ng/ml; R&D Systems). Cells were resuspended at a density of 1 Â 10 6 cells per ml in supernatants of cells transfected with a mouse stem cell-based retrovirus encoding Bcl-x L , previously incubated with polybrene (8 mg/ml) and diluted twofold with OMEM. Cells were spun at 1,000g for 90 min at 30 1C and then were incubated for 60 min at 37 1C. Cells were then collected and resuspended in pre-B cell culture medium with IL-7 (5 ng/ml) and were cultured for an additional 48 h, then were superinfected with either empty virus (MIT (mouse stem cell virusinternal ribosomal entry site-Thy-1.1)) or MIT-Cre. Cells were returned to culture with IL-7 and were analyzed 2d and 5 d later by flow cytometry. For RT-PCR, PCR and ChIP experiments, cells were collected 3 d after superinfection.
Southern blot analysis. DNA was purified from flow cytometry-sorted pro-B cells or magnetic bead-sorted splenic B cells by the salt-extraction method and was resuspended at a concentration of 25 ng/ml in TE buffer (10 mM Tris, pH 8, and 1 mM EDTA). PCR analysis of D H -to-J H , distal V H (V H J558)-to-(D)J H (J H 4), proximal V H (V H 7183)-to-(D)J H (J H 4), V k (V k Deg)-to-J k (MAR35K), V k -to-recombination signal or constant (C m ) recombination used DNA at a concentration of 100, 25, 6.25 or 1.56 ng/ml and 30 cycles as described 48 . Radiolabeled probes were synthesized with DNA polymerase Klenow fragment and PCR template generated from genomic DNA from wild-type splenic B cells. Southern blot analysis of heavy-and light-chain rearrangements was done as described 49, 50 .
ChIP. These assays were done essentially as described for the Acetyl-Histone H3 ChIP assay kit (Upstate Biotechnology) with minor modifications. First, a solution of 37% (vol/vol) formaldehyde was added directly to cultures of pro-B cells and/or pre-B cells to a final concentration of 1%, and cells were incubated for 10 min at 37 1C. Then, cells were collected and were washed twice with icecold PBS containing protease inhibitors (Roche) and were lysed for 10 min on ice with SDS lysis buffer. Lysates were sonicated to an average length of 200-1,000 base pairs and were clarified by centrifugation. Samples were diluted tenfold with ChIP dilution buffer, then were precleared for 1 h with protein A/G beads (Calbiochem), followed by incubation overnight at 4 1C with normal rabbit IgG (011-000-003; Jackson ImmunoResearch), anti-Foxo1 (H128 (Santa Cruz) or 9462 (Cell Signaling Technology)) or anti-E47 (554077; BD Pharmingen). Protein A/G beads were added in the final hour of incubation before collection. After washing and elution of beads according to the manufacturer's instructions, crosslinking was reversed by heating overnight
